Galmed Pharmaceuticals Ltd (GLMD)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.45M | -2M | -1.87M | -1.47M | -2.15M | -1.4M | -1.22M | -2.01M |
| Pre Tax Income | -2.64M | -1.83M | -1.59M | -1.47M | -2.02M | -1.28M | -1.12M | -1.91M |
| Net Income | -2.64M | -1.83M | -1.59M | -1.47M | -2.02M | -1.28M | -1.12M | -1.91M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -2.98M | -2M | -1.87M | -1.47M | -2.16M | -1.4M | -1.22M | -2.01M |
| EBITDA | -2.44M | -1.99M | -1.86M | -1.46M | -2.15M | -1.39M | -1.15M | -2.01M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 467k | 1.09M | 2.04M | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.88M | -12.36M | -10.72M | -22.38M | -30.21M | -32.88M | -17.65M | -7.49M |
| Pre Tax Income | -16.85M | -12.3M | -9.78M | -20.46M | -28.77M | -32.47M | -17.87M | -6.91M |
| Net Income | -16.95M | -12.3M | -9.86M | -20.46M | -28.77M | -32.47M | -17.87M | -6.91M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.395 | -0.852 | -0.469 | -0.968 | -1.349 | -1.294 | -0.709 | -1.37 |
| EBIT | -16.85M | -12.3M | -10.76M | -22.38M | -30.21M | -32.96M | -18.18M | -7.51M |
| EBITDA | -16.71M | -12.13M | -10.33M | -22.34M | -30.17M | -32.84M | -17.62M | -7.46M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
